A5019258050- Diet and metabolism studies
- SARS-CoV-2 and COVID-19 Research
- Heparin-Induced Thrombocytopenia and Thrombosis
- Dialysis and Renal Disease Management
- Cardiovascular Function and Risk Factors
- Diabetes Treatment and Management
- Cardiovascular Health and Risk Factors
- Iron Metabolism and Disorders
- COVID-19 Clinical Research Studies
- Blood Pressure and Hypertension Studies
- Metabolism, Diabetes, and Cancer
- Pharmacology and Obesity Treatment
- Complement system in diseases
- Nutritional Studies and Diet
- Central Venous Catheters and Hemodialysis
- Gut microbiota and health
- Liver Disease Diagnosis and Treatment
- Gastrointestinal motility and disorders
- Chronic Kidney Disease and Diabetes
- Erythropoietin and Anemia Treatment
- Heart Failure Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nutrition and Health in Aging
Hospital de La Ribera
2024
Instituto de Salud Carlos III
2024
Hospital Marina Baixa
2022
Hospital Costa del Sol
2022
Marine Technology Unit
2022
Patients on hemodialysis are at high-risk for complications derived from coronavirus disease 2019 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome 2 (SARS-CoV-2) infections humoral immunity 3 months after dose. This is multicentric prospective study assessing immunoglobulin G anti-Spike antibodies 6 9 initial SARS-CoV-2 vaccination in patients that had also received before 6-month assessment (early booster) or...
La reciente conceptualización del síndrome cardiovascular-reno-metabólico (CRM) por la American Heart Association (AHA) abre una oportunidad al abordaje multidisciplinar y desde etapas tempranas de vida en estratificación riesgo, prevención el tratamiento precoz círculo vicioso generado interacción factores riesgo cardiovasculares, renales metabólicos agravado desarrollo enfermedades cardiovasculares (incluyendo todo su espectro: insuficiencia cardíaca, fibrilación auricular, enfermedad...
The PROGRESER study is a multicentre, prospective, observational, 3-year follow-up of cohort patients with stage 3 chronic kidney disease (CKD) from different nephrology departments hospitals in the Spanish healthcare system. primary objective was to analyse risk factors for CKD progression, identifying possible differences between and without diabetes mellitus (DM). secondary if cardiovascular were also associated progression.
Background and Objectives: Sodium glucose cotransporter-2 (SGLT-2) inhibitors have emerged as integral therapeutic tools in the management of patients with cardiovascular–kidney–metabolic (CKM) syndrome. In addition to their well-documented effects on lowering levels cardiovascular- reno-protective actions, SGLT-2 inhibitors, through a reduction body weight (BW), generate changes composition volume status that not been clearly studied. Materials Methods: This retrospective, observational...